JSP Pharmaceutical Manufacturing (Thailand) PCL (BKK:JSP) Piotroski F-Score: 7 (As of Jul. 16, 2026) — Near Median

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BKK:JSP JSP Pharmaceutical Manufacturing (Thailand) PCL BKK:JSP
80 GF Score
Price ฿1.78
GF Value ฿3.16
Valuation Significantly Undervalued
! 5 Warning Signs
View Full Analysis

What is JSP Pharmaceutical Manufacturing (Thailand) PCL Piotroski F-Score?

JSP Pharmaceutical Manufacturing (Thailand) PCL BKK:JSP 80 Piotroski F-Score is 7 as of Jul. 16, 2026, which is at its 10-year median of 7.00. GuruFocus rates BKK:JSP with a GF Score™ of 80/100 and a GF Value™ of ฿3.16 (Significantly Undervalued). The stock has 5 warning signs investors should review. Among 1,912 Consumer Packaged Goods companies, JSP Pharmaceutical Manufacturing (Thailand) PCL ranks better than 88.39% on this metric.

Good Sign:

Piotroski F-Score is 7, indicates a very healthy situation.

The zones of discrimination were as such:

Good or high score = 7, 8, 9
Bad or low score = 0, 1, 2, 3

JSP Pharmaceutical Manufacturing (Thailand) PCL has an F-score of 7. It is a good or high score, which usually indicates a very healthy situation.

The historical rank and industry rank for JSP Pharmaceutical Manufacturing (Thailand) PCL's Piotroski F-Score or its related term are showing as below:

BKK:JSP' s Piotroski F-Score Range Over the Past 10 Years
Min: 3   Med: 7   Max: 8
Current: 7

During the past 7 years, the highest Piotroski F-Score of JSP Pharmaceutical Manufacturing (Thailand) PCL was 8. The lowest was 3. And the median was 7.

JSP Pharmaceutical Manufacturing (Thailand) PCL  (BKK:JSP) Piotroski F-Score Explanation

The developer of the system is Joseph D. Piotroski is relatively unknown accounting professor who shuns publicity and rarely gives interviews.

He graduated from the University of Illinois with a B.S. in accounting in 1989, received an M.B.A. from Indiana University in 1994. Five years later, in 1999, after earning a Ph.D. in accounting from the University of Michigan, he became an associate professor of accounting at the University of Chicago.

In 2000, he wrote a research paper called "Value Investing: The Use of Historical Financial Statement Information to Separate Winners from Losers" (pdf).

He wanted to see if he can develop a system (using a simple nine-point scoring system) that can increase the returns of a strategy of investing in low price to book (referred to in the paper as high book to market) value companies.

What he found was something that exceeded his most optimistic expectations.

Buying only those companies that scored highest (8 or 9) on his nine-point scale, or F-Score as he called it, over the 20 year period from 1976 to 1996 led to an average out-performance over the market of 13.4%.

Even more impressive were the results of a strategy of investing in the highest F-Score companies (8 or 9) and shorting companies with the lowest F-Score (0 or 1).

Over the same period from 1976 to 1996 (20 years) this strategy led to an average yearly return of 23%, substantially outperforming the average S&P 500 index return of 15.83% over the same period.


JSP Pharmaceutical Manufacturing (Thailand) PCL Piotroski F-Score Related Terms


JSP Pharmaceutical Manufacturing (Thailand) PCL Piotroski F-Score Historical Data

* Premium members only.

The historical data trend for JSP Pharmaceutical Manufacturing (Thailand) PCL's Piotroski F-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

JSP Pharmaceutical Manufacturing (Thailand) PCL Piotroski F-Score Chart

JSP Pharmaceutical Manufacturing (Thailand) PCL Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Piotroski F-Score
Get a 7-Day Free Trial N/A N/A 5.00 8.00 7.00

JSP Pharmaceutical Manufacturing (Thailand) PCL Quarterly Data
Mar21 Jun21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Piotroski F-Score Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 8.00 8.00 7.00 7.00 7.00

BKK:JSP vs KHC, GIS: Piotroski F-Score Comparison

For the Packaged Foods subindustry, JSP Pharmaceutical Manufacturing (Thailand) PCL's Piotroski F-Score, along with its competitors' market caps and Piotroski F-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


JSP Pharmaceutical Manufacturing (Thailand) PCL Piotroski F-Score vs Consumer Packaged Goods Industry

For the Consumer Packaged Goods industry and Consumer Defensive sector, JSP Pharmaceutical Manufacturing (Thailand) PCL's Piotroski F-Score distribution charts can be found below:

* The bar in red indicates where JSP Pharmaceutical Manufacturing (Thailand) PCL's Piotroski F-Score falls into.


BKK:JSP
80GF Score
JSP Pharmaceutical Manufacturing (Thailand) PCL BKK:JSP
Piotroski F-Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

How is the Piotroski F-Score calculated?

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

This Year (Mar26) TTM:Last Year (Mar25) TTM:
Net Income was 28.128 + 14.163 + 18.086 + 0.453 = ฿60.8 Mil.
Cash Flow from Operations was 18.272 + 23.271 + 57.482 + -9.89 = ฿89.1 Mil.
Revenue was 263.365 + 261.332 + 257.8 + 201.296 = ฿983.8 Mil.
Gross Profit was 110.454 + 103.882 + 101.671 + 75.676 = ฿391.7 Mil.
Average Total Assets from the begining of this year (Mar25)
to the end of this year (Mar26) was
(1337.595 + 1343.308 + 1345.408 + 1463.556 + 1478.145) / 5 = ฿1393.6024 Mil.
Total Assets at the begining of this year (Mar25) was ฿1,337.6 Mil.
Long-Term Debt & Capital Lease Obligation was ฿258.4 Mil.
Total Current Assets was ฿350.5 Mil.
Total Current Liabilities was ฿263.3 Mil.
Net Income was 14.178 + 32.549 + -39.737 + 7.491 = ฿14.5 Mil.

Revenue was 199.425 + 228.67 + 240.729 + 227.728 = ฿896.6 Mil.
Gross Profit was 70.788 + 90.837 + 100.102 + 89.541 = ฿351.3 Mil.
Average Total Assets from the begining of last year (Mar24)
to the end of last year (Mar25) was
(1371.711 + 1392.768 + 1443.632 + 1326.651 + 1337.595) / 5 = ฿1374.4714 Mil.
Total Assets at the begining of last year (Mar24) was ฿1,371.7 Mil.
Long-Term Debt & Capital Lease Obligation was ฿189.8 Mil.
Total Current Assets was ฿333.3 Mil.
Total Current Liabilities was ฿232.1 Mil.

*Note: If the latest quarterly/semi-annual/annual total assets data is 0, then we will use previous quarterly/semi-annual/annual data for all the items in the balance sheet.

Profitability

Question 1. Return on Assets (ROA)

Net income before extraordinary items for the year divided by Total Assets at the beginning of the year.

Score 1 if positive, 0 if negative.

JSP Pharmaceutical Manufacturing (Thailand) PCL's current Net Income (TTM) was 60.8. ==> Positive ==> Score 1.

Question 2. Cash Flow Return on Assets (CFROA)

Net cash flow from operating activities (operating cash flow) divided by Total Assets at the beginning of the year.

Score 1 if positive, 0 if negative.

JSP Pharmaceutical Manufacturing (Thailand) PCL's current Cash Flow from Operations (TTM) was 89.1. ==> Positive ==> Score 1.

Question 3. Change in Return on Assets

Compare this year's return on assets (1) to last year's return on assets.

Score 1 if it's higher, 0 if it's lower.

ROA (This Year)=Net Income/Total Assets (Mar25)
=60.83/1337.595
=0.04547714

ROA (Last Year)=Net Income/Total Assets (Mar24)
=14.481/1371.711
=0.01055689

JSP Pharmaceutical Manufacturing (Thailand) PCL's return on assets of this year was 0.04547714. JSP Pharmaceutical Manufacturing (Thailand) PCL's return on assets of last year was 0.01055689. ==> This year is higher. ==> Score 1.

Question 4. Quality of Earnings (Accrual)

Compare Cash flow return on assets (2) to return on assets (1)

Score 1 if CFROA > ROA, 0 if CFROA <= ROA.

JSP Pharmaceutical Manufacturing (Thailand) PCL's current Net Income (TTM) was 60.8. JSP Pharmaceutical Manufacturing (Thailand) PCL's current Cash Flow from Operations (TTM) was 89.1. ==> 89.1 > 60.8 ==> CFROA > ROA ==> Score 1.

Funding

Question 5. Change in Gearing or Leverage

Compare this year's gearing (long-term debt divided by average total assets) to last year's gearing.

Score 0 if this year's gearing is higher, 1 otherwise.

Gearing (This Year: Mar26)=Long-Term Debt & Capital Lease Obligation/Average Total Assets from Mar25 to Mar26
=258.363/1393.6024
=0.18539219

Gearing (Last Year: Mar25)=Long-Term Debt & Capital Lease Obligation/Average Total Assets from Mar24 to Mar25
=189.833/1374.4714
=0.13811346

JSP Pharmaceutical Manufacturing (Thailand) PCL's gearing of this year was 0.18539219. JSP Pharmaceutical Manufacturing (Thailand) PCL's gearing of last year was 0.13811346. ==> Last year is lower than this year ==> Score 0.

Question 6. Change in Working Capital (Liquidity)

Compare this year's current ratio (current assets divided by current liabilities) to last year's current ratio.

Score 1 if this year's current ratio is higher, 0 if it's lower

Current Ratio (This Year: Mar26)=Total Current Assets/Total Current Liabilities
=350.545/263.314
=1.33128128

Current Ratio (Last Year: Mar25)=Total Current Assets/Total Current Liabilities
=333.337/232.123
=1.43603607

JSP Pharmaceutical Manufacturing (Thailand) PCL's current ratio of this year was 1.33128128. JSP Pharmaceutical Manufacturing (Thailand) PCL's current ratio of last year was 1.43603607. ==> Last year's current ratio is higher ==> Score 0.

Question 7. Change in Shares in Issue

Compare the number of shares in issue this year, to the number in issue last year.

Score 0 if there is larger number of shares in issue this year, 1 otherwise.

JSP Pharmaceutical Manufacturing (Thailand) PCL's number of shares in issue this year was 453. JSP Pharmaceutical Manufacturing (Thailand) PCL's number of shares in issue last year was 468.188. ==> There is smaller number of shares in issue this year, or the same. ==> Score 1.

Efficiency

Question 8. Change in Gross Margin

Compare this year's gross margin (Gross Profit divided by sales) to last year's.

Score 1 if this year's gross margin is higher, 0 if it's lower.

Gross Margin (This Year: TTM)=Gross Profit/Revenue
=391.683/983.793
=0.39813558

Gross Margin (Last Year: TTM)=Gross Profit/Revenue
=351.268/896.552
=0.3917988

JSP Pharmaceutical Manufacturing (Thailand) PCL's gross margin of this year was 0.39813558. JSP Pharmaceutical Manufacturing (Thailand) PCL's gross margin of last year was 0.3917988. ==> This year's gross margin is higher. ==> Score 1.

Question 9. Change in asset turnover

Compare this year's asset turnover (total sales for the year divided by total assets at the beginning of the year) to last year's asset turnover ratio.

Score 1 if this year's asset turnover ratio is higher, 0 if it's lower

Asset Turnover (This Year)=Revenue/Total Assets at the Beginning of This Year (Mar25)
=983.793/1337.595
=0.73549393

Asset Turnover (Last Year)=Revenue/Total Assets at the Beginning of Last Year (Mar24)
=896.552/1371.711
=0.65360123

JSP Pharmaceutical Manufacturing (Thailand) PCL's asset turnover of this year was 0.73549393. JSP Pharmaceutical Manufacturing (Thailand) PCL's asset turnover of last year was 0.65360123. ==> This year's asset turnover is higher. ==> Score 1.

Evaluation

Piotroski F-Score= Que. 1+ Que. 2+ Que. 3+Que. 4+Que. 5+Que. 6+Que. 7+Que. 8+Que. 9
=1+1+1+1+0+0+1+1+1
=7

Good or high score = 7, 8, 9
Bad or low score = 0, 1, 2, 3

JSP Pharmaceutical Manufacturing (Thailand) PCL has an F-score of 7. It is a good or high score, which usually indicates a very healthy situation.

Frequently Asked Questions Learn more about Piotroski F-Score →
What does a Piotroski F-Score of 7 mean?
JSP Pharmaceutical Manufacturing (Thailand) PCL (BKK:JSP) has a Piotroski F-Score of 7 as of Jul. 16, 2026. The Piotroski F-score grades a company's business operating strength from 0-9. View historical data on JSP Pharmaceutical Manufacturing (Thailand) PCL and its competitors. This is near median its historical median of 7.00. Over the past decade, JSP Pharmaceutical Manufacturing (Thailand) PCL's Piotroski F-Score has ranged from 3.00 to 8.00. According to the industry distribution chart, JSP Pharmaceutical Manufacturing (Thailand) PCL ranks #222 out of 1912 companies in the Consumer Packaged Goods industry, placing it in the top 11.6%.
Is JSP Pharmaceutical Manufacturing (Thailand) PCL's Piotroski F-Score too high?
JSP Pharmaceutical Manufacturing (Thailand) PCL's current Piotroski F-Score of 7 is near median its 10-year median of 7.00. Over the past 10 years, this metric has ranged from a low of 3.00 to a high of 8.00. The Consumer Packaged Goods industry median Piotroski F-Score is 5.00. JSP Pharmaceutical Manufacturing (Thailand) PCL's value of 7 is 40% above this industry median. Based on the distribution chart, JSP Pharmaceutical Manufacturing (Thailand) PCL ranks #222 out of 1912 companies in the Consumer Packaged Goods industry, which is in the top quartile — a strong position relative to peers. Overall, JSP Pharmaceutical Manufacturing (Thailand) PCL has a GF Score™ of 80/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does JSP Pharmaceutical Manufacturing (Thailand) PCL's Piotroski F-Score compare to KHC and GIS?
According to the Consumer Packaged Goods industry distribution chart, JSP Pharmaceutical Manufacturing (Thailand) PCL ranks #222 out of 1912 companies for Piotroski F-Score. This places JSP Pharmaceutical Manufacturing (Thailand) PCL in the top 12% of its industry — outperforming the majority of peers. The industry median Piotroski F-Score is 5.00. JSP Pharmaceutical Manufacturing (Thailand) PCL's value of 7 is 40% above this benchmark. Historically, JSP Pharmaceutical Manufacturing (Thailand) PCL's own Piotroski F-Score has ranged from 3.00 to 8.00 over the past decade. While the company's 10-year median is 7.00 vs. the industry median of 5.00, JSP Pharmaceutical Manufacturing (Thailand) PCL has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Piotroski F-Score for a Consumer Packaged Goods company?
The median Piotroski F-Score among Consumer Packaged Goods companies is 5.00, based on 1,912 companies in the industry. Companies in the top quartile (top 25%) have a Piotroski F-Score significantly above this median, while those in the bottom quartile fall well below. However, Piotroski F-Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. JSP Pharmaceutical Manufacturing (Thailand) PCL's current Piotroski F-Score of 7 is 40% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Piotroski F-Score mean?
A high Piotroski F-Score can signal that a stock is expensive relative to its fundamentals. The Piotroski F-score grades a company's business operating strength from 0-9. View historical data on JSP Pharmaceutical Manufacturing (Thailand) PCL and its competitors. For the Consumer Packaged Goods industry, the median Piotroski F-Score is 5.00 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. JSP Pharmaceutical Manufacturing (Thailand) PCL's current Piotroski F-Score is 7, which is near median its own 10-year median of 7.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is JSP Pharmaceutical Manufacturing (Thailand) PCL stock overvalued right now?
Based on GuruFocus' analysis, JSP Pharmaceutical Manufacturing (Thailand) PCL (BKK:JSP) is currently considered Significantly Undervalued. The stock's GF Value™ is ฿3.16, compared to a current price of ฿1.78 — trading 43.7% below its estimated fair value. The current Piotroski F-Score is 7, which is near median its 10-year median of 7.00 and 40% above the Consumer Packaged Goods industry median of 5.00. JSP Pharmaceutical Manufacturing (Thailand) PCL's overall GF Score™ is 80/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Piotroski F-Score calculated?
Piotroski F-Score is calculated from a company's financial statements. For JSP Pharmaceutical Manufacturing (Thailand) PCL (BKK:JSP), the current Piotroski F-Score is 7 as of Jul. 16, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is JSP Pharmaceutical Manufacturing (Thailand) PCL (BKK:JSP) Overvalued in 2026?

Based on GuruFocus' analysis, JSP Pharmaceutical Manufacturing (Thailand) PCL stock appears to be undervalued. The current stock price of ฿1.78 is trading 43.7% below its estimated GF Value™ of ฿3.16. GuruFocus considers JSP Pharmaceutical Manufacturing (Thailand) PCL to be Significantly Undervalued.

Key valuation signals for BKK:JSP:

  • Piotroski F-Score: 7 (near median its 10-year median of 7.00)
  • GF Value™: ฿3.16 vs. price of ฿1.78 (43.7% below fair value)
  • GF Score™: 80/100 with 5 warning signs
  • Industry Position: 40% above the Consumer Packaged Goods median (#222 of 1912)

No single metric tells the full story. See the BKK:JSP stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


JSP Pharmaceutical Manufacturing (Thailand) PCL Business Description

Address No. 255, 257 Soi Sathupradit 58, Bang Pongphang, Yan Nawa, Bangkok, THA, 10120
JSP Pharmaceutical Manufacturing (Thailand) PCL is engaged in producing modern medicine, traditional medicine, herbal products, dietary supplements, medical supplies, and cleaning alcohol under the client's and the company's own trademarks. Maximum revenue for the company is generated from the sale of dietary supplements. The Group's reportable operating segments are: Manufacture and distribution of products under the company's brand name (Own brands), which generate maximum revenue, Manufacture and distribution of products under customers' brand name (OEM), Manufacture and distribution of hemodialysis solution and related medical supplies; and Service, research and development, and healthcare products training. Geographically, it operates principally in Thailand.
80GF Score

Get the complete analysis for BKK:JSP

Piotroski F-Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

฿1.78
Price
฿3.16
GF Value